Ohh-med Company, operated from within Medimor Campus, is entering initial production stage of its new medical product named Vertica. This product assist in overcoming erectile dysfunction issues using RF technology, a method proved to be very advantageous in esthetic treatments. This technology is based on the company’s founder & CEO, Daniel Lischinsky, which developed Endymed’s RF technology for skin tightening.
Daniel Lischinsky is considered one of Israel’s technologies pioneers, and served in senior developments positions at LSI Logic, Zoran Semiconductors and Saifun Semiconductors and was in charge for developing attribution plans at Mellanox Technologies. The idea of founding Ohh-med was born in 2016, when he read an article regarding Collagen’s role in the sexual processes. The ability of RC radiation to encourage Collagen fibers’ growing is a well familiar phenomenon, used in various medical implementations. The mentioned article brought experimental results, showing that the weakness of the Collagen tissue is responsible for erectile dysfunction. In conversation with Techtime, he recalls that this was the moment he realized RF technology might assist in resolving these issues.
Lischinsky crafted a homemade prototype, which was clinically tested in Rambam Medical Center in Haifa. Following successful results (twice of Viagra efficiency), he received marketing license from the Israeli Ministry of Health, and the product is currently pending European certification (CE) approval. Ohh-med is now being arranged for a wide clinical experiment in order to file an FDA request. The device is based on connectors system, transferring AC currents through the penis, in a 1MHz frequency and a strength of 200-350mA.
The target: Producing 10,000 devices monthly
Main advantage of this technology is that the treatment is taking place at the patient’s house, completely privately and during its convenient free time. Also, it is highly safe, as temperature sensors assures the heat will not exceed 42°C (107°F). Lischinsky: “up to date, the company had raised several million dollars (less than 10), and another raising is expected by the end of 2022. This month we started with the first batch production of 2,500 devices in the Medimor factory at Tiberius. Next month we plan to increase the production by several more thousands, and we estimate a production capability of 10,000 in 2023”.
“Our solution helps many persons, generating no side effects nor suffer. From data known to the medical world, it seems that there is a correlation between the rates of men suffers from erectile dysfunction and their age: around 40%of them are in their forties, and around 60% are in their sixties. We are touching a painful issue in many people’s lives. Since we launched our public website in November 2021, a lot of men aged 35 to 65, showed interest by browsing it. We also noticed that almost 40% of our website’s visitors were women’.